Table I.
Clinicopathological characteristics of patients with high stage (II–IV) upper-tract urothelial carcinoma.
| Clinicopathological characteristic | Value |
|---|---|
| Age (years); median (range) | 70.0 (26–86) |
| Sexa | |
| Male | 43 (34.1) |
| Female | 83 (65.9) |
| eGFR (ml/min)a | |
| >60 | 30 (23.8) |
| <60 | 96 (76.2) |
| Pathological stagea | |
| II | 38 (30.2) |
| III | 73 (57.9) |
| IV | 15 (11.9) |
| Gradea | |
| Low | 35 (27.8) |
| High | 91 (72.2) |
| Lymphovascular invasiona | |
| No | 80 (63.5) |
| Yes | 46 (36.5) |
| Perineural permeationa | |
| No | 104 (82.5) |
| Yes | 22 (17.5) |
| Locationa | |
| Ureter | 52 (41.3) |
| Renal pelvis | 74 (58.7) |
| Lymph node metastasisa | |
| Negative | 121 (96.0) |
| Positive | 5 (4.0) |
a
Data are presented as number of patients (%). eGFR, estimated glomerular filtration rate.